![]() |
市場調查報告書
商品編碼
1843381
2021-2031 年北美止咳糖市場報告(範圍、細分、動態和競爭分析)North America Cough Drops Market Report 2021-2031 by Scope, Segmentation, Dynamics, and Competitive Analysis |
北美止咳糖市場預計將大幅成長,到 2031 年將達到約 9.1014 億美元,高於 2023 年的 5.8021 億美元,在此期間的年複合成長率(CAGR) 為 5.8%。
執行摘要和市場分析
北美止咳糖市場呈現穩定成長態勢,這主要得益於消費者對呼吸系統健康的意識不斷增強,以及感冒和流感症狀的增多,尤其是在季節變化期間。市場提供種類繁多的產品,包括薄荷醇類、草本類和無醣類止咳糖,以滿足不同消費者的偏好。美國憑藉其龐大的人口、高昂的醫療支出以及強大的零售網路,佔據了市場主導地位。利口樂 (Ricola)、豪氏 (Halls)(億滋國際)和 Luden's 等主要品牌正在積極創新,推出新口味並添加維生素 C 和鋅等功能性成分,以滿足不斷變化的消費者需求。電子商務的成長以及人們對天然和有機產品的日益青睞,進一步豐富了市場產品種類。此外,新冠疫情 (COVID-19) 疫情加劇了人們對免疫力的關注,導致對治療性潤喉糖的需求增加。隨著人們對預防性醫療保健和健康的興趣日益濃厚,預計北美止咳糖市場在未來幾年將繼續保持上升趨勢。
市場區隔分析
北美止咳藥市場可按產品類型、應用和配銷通路細分:
市場展望
感冒和流感等常見呼吸道疾病是導致喉嚨痛症狀的重要因素。根據世界衛生組織統計,全球每年約有10億例季節性流感病例,其中300萬至500萬例為重症病例。症狀通常在感染後1-4天出現,並永續約一週。普通感冒、流感和季節性過敏的流行推動了對止咳產品的需求,因為消費者希望能夠立即緩解咳嗽和咽喉刺激等症狀。
快速城市化導致空氣品質惡化,引發了人們對呼吸健康的擔憂,導致呼吸系統疾病病例增加。污染物會加劇氣喘和支氣管炎等疾病,促使消費者尋求止咳藥物來緩解症狀。由於免疫力下降和現有的健康問題,老齡人口特別容易患上呼吸系統疾病。世界衛生組織預測,到 2030 年,全球每 6 人中就有 1 人年齡在 60 歲或以上,預計到 2050 年 80 歲及以上人口的數量將增加兩倍。隨著年齡的成長,人們更容易患上需要症狀管理的慢性疾病,包括使用止咳藥。慢性肺部疾病和免疫抑制發生率的上升導致老年人呼吸道感染增加。因此,在呼吸系統疾病負擔日益加重的推動下,製造商正在創新其產品線並建立合作夥伴關係以擴大市場佔有率。
國家洞察
北美止咳糖市場包括美國、加拿大和墨西哥,其中美國在2023年佔最大市場佔有率。美國市場的發展受到消費者偏好變化和對健康保健日益成長的關注的驅動。感冒和過敏等呼吸系統疾病的日益流行,導致非處方止咳和咽喉舒緩產品的需求激增。消費者越來越青睞天然和草藥療法,促使製造商不斷創新,推出包含草藥萃取物、維生素和精油的產品。例如,2021年10月,HALLS與體育解說員喬·巴克合作推出了HALLS minis無糖止咳糖。電子商務改變了止咳糖的購買格局,為消費者提供了更大的可及性和便利性。與傳統零售店相比,線上平台允許產品比較、評論和更廣泛的選擇。呼吸系統疾病的季節性高峰推動了銷售,消費者紛紛購買止咳產品,行銷策略利用社群媒體和線上廣告來吸引年輕族群。
公司簡介
北美止咳糖市場的主要參與者包括 Bliss GVS Pharma Ltd、Cipla Ltd、Gepach International、葛蘭素史克公司 (GSK Plc)、億滋國際 (Mondelez International Inc)、利潔時集團 (Reckitt Benckiser Group Plc)、利口樂 (Ricola)、賽諾菲 (Sanofixer這些公司正在採取各種策略,包括擴張、產品創新和併購,以增強產品線並提高市場佔有率。
The North America Cough Drops Market is projected to grow significantly, reaching approximately US$ 910.14 million by 2031, up from US$ 580.21 million in 2023, with a compound annual growth rate (CAGR) of 5.8% during this period.
Executive Summary and Market Analysis
The cough drops market in North America has shown steady growth, primarily due to increased consumer awareness about respiratory health and a rise in cold and flu symptoms, especially during seasonal changes. This market offers a wide range of products, including menthol-based, herbal, and sugar-free cough drops, catering to diverse consumer preferences. The United States dominates the market, benefiting from a large population, significant healthcare expenditures, and a robust retail network. Major brands such as Ricola, Halls (Mondelez), and Luden's are actively innovating by introducing new flavors and incorporating functional ingredients like vitamin C and zinc to meet evolving consumer demands. The growth of e-commerce and a rising preference for natural and organic products have further diversified the market offerings. Additionally, the COVID-19 pandemic has heightened the focus on immunity, leading to increased demand for therapeutic lozenges. With a growing interest in preventive healthcare and wellness, the North America cough drops market is expected to continue its upward trajectory in the coming years.
Market Segmentation Analysis
The North America cough drops market can be segmented by product type, application, and distribution channel:
Market Outlook
Common respiratory issues such as colds and influenza are significant contributors to sore throat symptoms. According to the World Health Organization, around 1 billion cases of seasonal influenza occur globally each year, with 3-5 million cases classified as severe. Symptoms typically manifest 1-4 days post-infection and can last about a week. The prevalence of the common cold, flu, and seasonal allergies drives demand for cough relief products as consumers seek immediate alleviation from symptoms like coughing and throat irritation.
Deteriorating air quality due to rapid urbanization has raised concerns about respiratory health, leading to increased cases of respiratory illnesses. Pollutants exacerbate conditions such as asthma and bronchitis, prompting consumers to seek cough drops for relief. The aging population is particularly susceptible to respiratory disorders due to weakened immunity and existing health issues. The World Health Organization projects that by 2030, 1 in 6 individuals globally will be aged 60 or older, with the number of people aged 80 and above expected to triple by 2050. As individuals age, they are more likely to experience chronic illnesses that necessitate symptom management, including the use of cough drops. The rising incidence of chronic lung diseases and immunosuppression is contributing to increased respiratory infections among older adults. Consequently, manufacturers are innovating their product lines and forming partnerships to expand their market presence, driven by the growing burden of respiratory diseases.
Country Insights
The North America cough drops market includes the US, Canada, and Mexico, with the US holding the largest market share in 2023. The US market is driven by changing consumer preferences and a heightened focus on health and wellness. The increasing prevalence of respiratory conditions, such as colds and allergies, has led to a surge in demand for over-the-counter cough and throat-soothing products. Consumers are increasingly favoring natural and herbal remedies, prompting manufacturers to innovate with products that include herbal extracts, vitamins, and essential oils. For example, in October 2021, HALLS launched HALLS minis Sugar-Free Cough Drops in collaboration with sportscaster Joe Buck. E-commerce has transformed the purchasing landscape for cough drops, providing consumers with greater accessibility and convenience. Online platforms allow for product comparisons, reviews, and a wider selection than traditional retail stores. Seasonal peaks in respiratory illnesses drive sales as consumers stock up on cough relief products, with marketing strategies leveraging social media and online advertising to engage younger demographics.
Company Profiles
Key players in the North America cough drops market include Bliss GVS Pharma Ltd, Cipla Ltd, Gepach International, GSK Plc, Mondelez International Inc, Reckitt Benckiser Group Plc, Ricola, Sanofi SA, The Procter & Gamble Co, and Thornton & Ross. These companies are pursuing various strategies, including expansion, product innovation, and mergers and acquisitions, to enhance their offerings and increase market share.